Marksans Pharma gets USFDA approval for Esomeprazole Magnesium Capsules

October 3, 2023
News
55 secs read

Source: Business Standard

Mumbai-headquartered pharma company Marksans Pharma announced on Tuesday that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC).

Esomeprazole, the active ingredient in these capsules, is used for treating various stomach and oesophagus-related issues, such as acid reflux and ulcers. It operates by reducing the production of stomach acid, and providing relief from symptoms such as heartburn, swallowing difficulties, and coughing.

Moreover, this medication also heals acid-induced damage to the stomach and oesophagus, preventing ulcers, and is expected to help in reducing the risk of oesophageal cancer. Esomeprazole belongs to the class of drugs known as proton pump inhibitors (PPIs).

This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed-Release Capsules, 20 mg (OTC), of AstraZeneca Pharmaceuticals LP.

The product will be manufactured at Marksans Pharma’s formulation manufacturing facility in Goa, India.

Marksans Pharma operates in the research, manufacturing, and marketing of generic pharmaceutical formulations in global markets. The company has manufacturing facilities in India, the USA, and the UK.

Pharmaways

Pharmaways Global Private Limited is a company established in 2022. Headed by a group of professionals with over 25 years of experience. A team of professionals who have excelled in their respective fields of Pharma, Legal & Information Technology. We have global exposure and hands-on experience of the global Pharma industry. We are in pursuit of bringing the global Pharma Industry on a platform where they can connect, collaborate and work towards mutual growth. We have taken a step into the future by innovating a technology that will help global Pharma players to empower, excel and accelerate in their business. A platform that has been developed exclusively for the Pharma fraternity. We are a New Delhi based company with overseas offices in America and the United Kingdom.